Follow
Krzysztof Mrůzek
Krzysztof Mrůzek
Research Scientist, The Ohio State University
Verified email at osumc.edu
Title
Cited by
Cited by
Year
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid†…
JC Byrd, K Mrůzek, RK Dodge, AJ Carroll, CG Edwards, DC Arthur, ...
Blood 100 (13), 4325-4336, 2002
20932002
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England Journal of Medicine 371 (11), 1005-1015, 2014
14882014
Cytogenetics in acute leukemia
K Mrůzek, NA Heerema, CD Bloomfield
Blood Reviews 18 (2), 115-136, 2004
9722004
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrůzek, D Margeson, ...
Journal of Clinical Oncology 28 (14), 2348-2355, 2010
9592010
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B study
P Paschka, G Marcucci, AS Ruppert, K Mrůzek, H Chen, RA Kittles, ...
Journal of Clinical Oncology 24 (24), 3904-3911, 2006
8642006
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a Cancer†…
SP Whitman, KJ Archer, L Feng, C Baldus, B Becknell, BD Carlson, ...
Cancer Research 61 (19), 7233-7239, 2001
8242001
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular†…
K Mrůzek, G Marcucci, P Paschka, SP Whitman, CD Bloomfield
Blood 109 (2), 431-448, 2007
8082007
MicroRNA expression in cytogenetically normal acute myeloid leukemia
G Marcucci, MD Radmacher, K Maharry, K Mrůzek, AS Ruppert, ...
New England Journal of Medicine 358 (18), 1919-1928, 2008
5402008
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia
K Mrůzek, G Marcucci, D Nicolet, KS Maharry, H Becker, SP Whitman, ...
Journal of Clinical Oncology 30 (36), 4515-4523, 2012
5282012
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Z Gu, ML Churchman, KG Roberts, I Moore, X Zhou, J Nakitandwe, ...
Nature Genetics 51 (2), 296-307, 2019
4682019
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study
G Marcucci, K Mrůzek, AS Ruppert, K Maharry, JE Kolitz, JO Moore, ...
Journal of Clinical Oncology 23 (24), 5705-5717, 2005
4492005
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study
KH Metzeler, K Maharry, MD Radmacher, K Mrůzek, D Margeson, ...
Journal of Clinical Oncology 29 (10), 1373-1381, 2011
4302011
High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults
KG Roberts, Z Gu, D Payne-Turner, K McCastlain, RC Harvey, IM Chen, ...
Journal of Clinical Oncology 35 (4), 394-401, 2017
4292017
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene-and microRNA-expression†…
H Becker, G Marcucci, K Maharry, MD Radmacher, K Mrůzek, ...
Journal of Clinical Oncology 28 (4), 596-604, 2010
4282010
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B experience
M Wetzler, RK Dodge, K Mrůzek, AJ Carroll, R Tantravahi, AMW Block, ...
Blood 93 (11), 3983-3993, 1999
3851999
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk†…
G Marcucci, K Maharry, MD Radmacher, K Mrůzek, T Vukosavljevic, ...
Journal of Clinical Oncology 26 (31), 5078-5087, 2008
3772008
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
W Stock, SM Luger, AS Advani, J Yin, RC Harvey, CG Mullighan, ...
Blood 133 (14), 1548-1559, 2019
3752019
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia†…
SS Farag, KJ Archer, K Mrůzek, AS Ruppert, AJ Carroll, JW Vardiman, ...
Blood 108 (1), 63-73, 2006
3642006
Clinical significance of cytogenetics in acute myeloid leukemia.
K Mrůzek, K Heinonen, A de la Chapelle, CD Bloomfield
Seminars in Oncology 24 (1), 17-31, 1997
3631997
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal†…
SP Whitman, AS Ruppert, MD Radmacher, K Mrůzek, P Paschka, ...
Blood, The Journal of the American Society of Hematology 111 (3), 1552-1559, 2008
3612008
The system can't perform the operation now. Try again later.
Articles 1–20